Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Scientists at La Trobe University have identified a possible defense for humans against the influenza virus H5N1—commonly ...

Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...

Immune cells might be reprogrammed to use the body’s fructose — a naturally occurring sugar — as an energy source that supercharges them to fight cancer, researchers at Memorial Sloan Kettering Cancer ...

A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI).

The new research reveals how a protein in brain cells may drive Parkinson's onset—and offers a possible explanation for why Parkinson's is much more common in men.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, 'CARsgen Therapeutics'), a company focused on innovative CAR ...

Aim to accelerate clinical timelines, reduce manufacturing bottlenecks, and enhance scalability, to bring Swarm's T cell ...